Performance of the scale for assessment of positive symptoms in Parkinson's disease psychosis

Movement Disorders

Volumn 25, Issue 1, 2010, Pages 124-125

  Voss, Tiffini S ^a   Brocht, Alicia F D ^a   Ravina, Bernard ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; PLACEBO;

BEHAVIOR DISORDER; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; DELUSION; HALLUCINATION; HUMAN; INAPPROPRIATE AFFECT; LETTER; MINI MENTAL STATE EXAMINATION; PARKINSON DISEASE; POSITIVE FORMAL THOUGHT DISORDER; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; SCALE FOR ASSESSMENT OF POSITIVE SYMPTOMS; SCHIZOPHRENIA; STRUCTURED INTERVIEW; THOUGHT DISORDER;

BRIEF PSYCHIATRIC RATING SCALE; DELUSIONS; HALLUCINATIONS; HUMANS; PARKINSON DISEASE; PSYCHOTIC DISORDERS; SENSITIVITY AND SPECIFICITY;

EID: 75749125318     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22575     Document Type: Letter

References (4)

1. Fernandez HH, Aarsland D, Fénelon G, et al. Scales to assess psychosis in Parkinson's disease: critique and recommendations. Mov Disord 2008;23:484-500.
2. Andreasen NC. The scale for assessment of positive symptoms (SAPS). Iowa City, IA: The University of Iowa; 1984.
3. The Parkinson Study Group. Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. N Engl J Med 1999;340:757-763.
4. Ravina B, Marder K, Fernandez HH, et al. Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov Disord 2007;22:1061-1068.